SCHEMBL21366090

SCHEMBL21366090

CC(C)(C)c1csc(-c2ncno2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.36
CCR4 P51679 6/20 0.34
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
MAPT P10636 2/20 0.33
PKM P14618 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
RECQL P46063 1/20 0.33
KMT2A Q03164 1/20 0.33
HTR1A P08908 1/20 0.33
HTR2A P28223 1/20 0.33
HTR7 P34969 1/20 0.33
ALDH1A1 P00352 2/20 0.32
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
ATAD2 Q6PL18 1/20 0.31
NPC1 O15118 1/20 0.30
RAB9A P51151 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21547875 0.77 PDE10A (0.42) LMNAMAPTNPSR1MEN1KMT2A
SCHEMBL18157876 0.75 CCR4 (0.46) LMNACCR4CNR1CNR2MAPT
SCHEMBL21366093 0.70 NOTUM (0.40) LMNACCR4CNR1CNR2MAPT
SCHEMBL20333959 0.67 CCR4 (0.34) LMNACCR4CNR1CNR2MAPT
SCHEMBL4617705 0.66 KDM4E (0.39) LMNACCR4CNR1CNR2MAPT
SCHEMBL10183532 0.65 KDM4E (0.54) LMNACCR4CNR1CNR2MAPT
SCHEMBL8215623 0.65 RAB9A (0.54) LMNACCR4CNR1CNR2MAPT
SCHEMBL10025209 0.65 SREBF2 (0.54) LMNACCR4MAPTPKMMEN1
SCHEMBL12636848 0.64 LMNA (0.46) LMNACCR4MAPTNPSR1MEN1
SCHEMBL17773148 0.63 CYP19A1 (0.46) LMNACCR4MAPTPKMMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11547698-B2 Aryl hydrocarbon receptor modulators ARIAGEN, INC. (US) 2023-01-10 US disclosed
US-20190330201-A1 ARYL HYDROCARBON RECEPTOR MODULATORS AHR PHARMACEUTICALS, INC. 2019-10-31 US disclosed
US-20190307731-A1 ARYL HYDROCARBON RECEPTOR MODULATOR ARIAGEN, INC. (US) 2019-10-10 US disclosed
US-20190284149-A1 ARYL HYDROCARBON RECEPTOR MODULATOR ARIAGEN, INC. (US) 2019-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190307731-A1 ARYL HYDROCARBON RECEPTOR MODULATOR AHR, ARNT, NR1H4 LMNA 3934/4885CCR4 398/4885CNR1 22/4885
US-11547698-B2 Aryl hydrocarbon receptor modulators AHR, ARNT, CNR1 LMNA 3998/4885CCR4 487/4885CNR1 3/4885
US-20190284149-A1 ARYL HYDROCARBON RECEPTOR MODULATOR AHR, ARNT, NR1H4 LMNA 3597/4885CCR4 318/4885CNR1 20/4885
US-20190330201-A1 ARYL HYDROCARBON RECEPTOR MODULATORS AHR, ARNT, CNR1 LMNA 3998/4885CCR4 487/4885CNR1 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.